Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ROC analysis as an additional method to characterize time to event data.

Horst J Koch1, Peter Hau

  • 1Neurologische Universitätsklinik Regensburg, Regensburg 93053, Germany. horst.koch@medbo.de

Pathology Oncology Research : POR
|April 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

End-of-life challenges in neuro-oncological patient care: A survey from the Junge Neuroonkologische Arbeitsgemeinschaft.

Neuro-oncology practice·2026
Same author

European neuro-oncology quality assessment (ENOQUA): A European organization for the research and treatment of cancer (EORTC) brain tumor group research project.

Neuro-oncology practice·2026
Same author

ClpP activation in high-risk medulloblastoma: ONC206 as a potent inducer of the integrated stress response and mitochondrial damage for a broader therapeutic window.

Neuro-oncology·2026
Same author

Preventive strategies against brain metastases: current state of the art and future directions.

Neurological research and practice·2026
Same author

Palliative care interventions and outcome in patients with glioblastoma - a retrospective, single-center study.

BMC palliative care·2026
Same author

Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial.

The Lancet. Oncology·2025

Receiver Operating Characteristic (ROC) analysis can compare survival data in oncology, offering new insights beyond diagnostic testing. This method aids in distinguishing between therapeutic approaches and tumor grades for brain tumors.

Area of Science:

  • Oncology
  • Biostatistics
  • Medical Diagnostics

Background:

  • Receiver Operating Characteristic (ROC) analysis is primarily used for evaluating diagnostic test accuracy.
  • Comparing survival data in oncology often relies on traditional methods like Kaplan-Meier analysis.

Purpose of the Study:

  • To explore the utility of ROC analysis as a supplementary method for comparing survival data in oncology.
  • To assess the effectiveness of ROC analysis in differentiating between treatment outcomes and tumor characteristics.

Main Methods:

  • Survival data from brain tumor patients were analyzed.
  • Conventional Kaplan-Meier method was employed for comparison.
  • Receiver Operating Characteristic (ROC) analysis was applied to the survival data.

Related Experiment Videos

Main Results:

  • The Area Under the Curve (AUC) from ROC analysis provided additional illustrative information.
  • ROC analysis demonstrated potential in distinguishing between different therapeutic approaches.
  • The method also showed utility in differentiating between low-grade and high-grade brain tumors.

Conclusions:

  • ROC analysis offers a valuable alternative or complementary method for analyzing oncology survival data.
  • The application of ROC curves can enhance the interpretation of treatment efficacy and prognostic factors in cancer research.